tiprankstipranks
BioNano Genomics Inc (BNGO)
NASDAQ:BNGO
US Market

BioNano Genomics (BNGO) Stock Forecast & Price Target

Compare
9,176 Followers
See the Price Targets and Ratings of:

BNGO Financial Forecast

BNGO Earnings Forecast

Next quarter’s earnings estimate for BNGO is -$5.90 with a range of -$6.00 to -$5.80. The previous quarter’s EPS was -$31.20. BNGO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.06% of the time in the same period. In the last calendar year BNGO has Outperformed its overall industry.
Next quarter’s earnings estimate for BNGO is -$5.90 with a range of -$6.00 to -$5.80. The previous quarter’s EPS was -$31.20. BNGO beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.06% of the time in the same period. In the last calendar year BNGO has Outperformed its overall industry.

BNGO Sales Forecast

Next quarter’s sales forecast for BNGO is $6.20M with a range of $6.00M to $6.40M. The previous quarter’s sales results were $6.07M. BNGO beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.69% of the time in the same period. In the last calendar year BNGO has Outperformed its overall industry.
Next quarter’s sales forecast for BNGO is $6.20M with a range of $6.00M to $6.40M. The previous quarter’s sales results were $6.07M. BNGO beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.69% of the time in the same period. In the last calendar year BNGO has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
BTIG
Hold
Reiterated
11/17/24
Hold Rating on BioNano Genomics Amid Revenue Shortfall and Strategic Shift
Scotiabank
$1
Hold
-81.34%
Downside
Reiterated
11/15/24
Scotiabank Sticks to Their Hold Rating for BioNano Genomics (BNGO)
Ladenburg Thalmann & Co.
Hold
Downgraded
11/15/24
Bionano Genomics downgraded to Neutral from Buy at LadenburgBionano Genomics downgraded to Neutral from Buy at Ladenburg
Maxim Group
Hold
Reiterated
08/08/24
Maxim Group Reaffirms Their Hold Rating on BioNano Genomics (BNGO)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioNano Genomics

Currently, no data available
Please return soon. This page is being updated.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BNGO Analyst Recommendation Trends

Rating
Mar 24
May 24
Aug 24
Sep 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
4
6
7
5
2
Hold
2
1
3
3
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
7
10
8
7
In the current month, BNGO has received 2 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. BNGO average Analyst price target in the past 3 months is $1.00.
Each month's total comprises the sum of three months' worth of ratings.

BNGO Stock Forecast FAQ

What is BNGO’s average 12-month price target, according to analysts?
Based on analyst ratings, BioNano Genomics Inc’s 12-month average price target is $1.00.
    What is BNGO’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for BNGO, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is BNGO a Buy, Sell or Hold?
        BioNano Genomics Inc has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is BioNano Genomics Inc’s price target?
          The average price target for BioNano Genomics Inc is $1.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents -81.34% Decrease from the current price of $5.36.
            What do analysts say about BioNano Genomics Inc?
            BioNano Genomics Inc’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of BNGO?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis